Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Ross Fiziol Zh Im I M Sechenova ; 88(7): 842-50, 2002 Jul.
Artigo em Russo | MEDLINE | ID: mdl-12238351

RESUMO

It has been shown that mu-opioid receptor stimulation by intravenous administration of the selective mu receptor agonist DALDA in a dose of 0.1 mg/kg prevented ischemic and reperfusion arrhythmias in rats subjected to coronary artery occlusion (10 min) and reperfusion (10 min), and also increased the ventricular fibrillation threshold in rats with postinfarction cardiac fibrosis. These effects were abolished by pre-treatment with the selective mu receptor antagonist CTAP in a dose of 0.5 mg/kg or by prior injection of the opioid receptor antagonist naloxone methiodide (2 mg/kg) which does not penetrate the blood-braib barrier. Both antagonists by themselves had no effect on the incidence of occlusion or reperfusion-induced arrhythmias or on the ventricular fibrillation threshold. Pre-treatment with ATP-sensitive K+ channel (KATP channel) blocker glibenclamide in a dose of 0.3 mg/kg completely abolished the antiarrhythmic effect of DALDA. We believe that DALDA prevents occurrence of electrical instability during ischemia and reperfusion and increases the ventricular fibrillation threshold in rats with postinfarction cardiac fibrosis via stimulation of peripheral mu-opioid receptor which appear to be coupled to the KATP channel.


Assuntos
Isquemia Miocárdica/fisiopatologia , Traumatismo por Reperfusão Miocárdica/fisiopatologia , Naloxona/análogos & derivados , Canais de Potássio/fisiologia , Receptores Opioides mu/fisiologia , Animais , Eletrocardiografia , Infarto do Miocárdio/patologia , Infarto do Miocárdio/fisiopatologia , Naloxona/farmacologia , Oligopeptídeos/farmacologia , Fragmentos de Peptídeos , Peptídeos/farmacologia , Compostos de Amônio Quaternário , Ratos , Ratos Wistar , Receptores Opioides mu/agonistas , Receptores Opioides mu/antagonistas & inibidores , Esclerose , Somatostatina
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...